¼¿ï´ëÇб³º´¿ø Á¦ 11 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãá°èÇмú´ëȸ : 2019-04-13±³À°ÀÏÀÚ : 2019-04-13
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦
±³À°ÁÖÁ¦ :
Á¦ 11 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ
´ã´çÀÚ : ÁÖÁöÇö
¿¬¶ôó : 02-2072-0629
À̸ÞÀÏ :
joojihyun0512@gmail.com ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 75¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 09:30~10:00 µî·Ï ()
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 10:00~10:40 Comprehensive review on Autoimmune Encephalitis ÁÖ°Ç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 10:40~11:00 Clinical assessment scale in AE (CASE scoring) ÀÓÁ¤¾Æ(ÇѸ²´ë°³²¼º½Éº´¿ø)
ÈÞ½Ä 04-13 ¼¼ºÈ¯¿¬±¸È¦ 11:00~11:15 COFFEE BREAK ()
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 11:15~12:00 What a rheumatologist knows about brain ¹ÚÁø±Õ(¼¿ï´ëº´¿ø)
½Ä»ç 04-13 ¼¼ºÈ¯¿¬±¸È¦ 12:00~13:15 LUNCH ()
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 13:15~13:45 Recent developments in myasthenia gravis È«À±È£(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 13:45~14:15 MOG encephalomyelitis-discoveries ±è¼º¹Î(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 14:15~14:45 Autoimmune encephalitis-discoveries À̼øÅÂ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 14:45~15:00 Discussion À̼øÅÂ(Çмú±³À°ÀÌ»ç)
ÈÞ½Ä 04-13 ¼¼ºÈ¯¿¬±¸È¦ 15:00~15:15 COFFEE BREAK ()
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 15:15~15:30 16S sequencing for polymicrobial infection ¹®Àå¼·(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 15:30~15:45 Combination therapy of immunoglobulin, Rituximab,and Tocilizumab in treating acute autoimmune encephalitis ÀÌ¿ìÁø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 15:45~16:00 AE by cancer immunotherapy (irAE) ÀåÇý¿¬(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 16:00~16:15 Treatment options for Japanese B encephalitis ¼ÕÈ¿½Å(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 16:15~16:30 Loss of neurovascular coupling in NMDAR encephalitis ÀÌÇÑ»ó(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-13 ¼¼ºÈ¯¿¬±¸È¦ 16:30~16:45 Summary and perspectives ±è¸¸È£(´ëÇѳú¿°/³ú¿°ÁõÇÐȸ ȸÀå)